Immune Infiltration and Prostate Cancer

It is becoming increasingly clear that inflammation influences prostate cancer development and that immune cells are among the primary drivers of this effect. This information has launched numerous clinical trials testing immunotherapy drugs in prostate cancer patients. The results of these studies are promising but have yet to generate a complete response. Importantly, the precise immune profile that determines clinical outcome remains...